Vicious cycles – decoding the patterns of suicide risk

Losing it

There can be few outcomes that a healthcare professional dreads more than their patient prematurely ending their own life. However, given the social taboos around discussing suicide, spotting ideation early enough to stop it becoming action is a challenge.

This challenge is especially great in psychiatry, an area with a high risk of suicide. Of those people who die by suicide, 90% or more are suffering from mental health issues at the time of their deaths and, for psychiatrists treating bipolar disorder, up to half of their patients are likely to attempt suicide at some point1,2.

 

The cruelest months

 

Understanding the influences behind peaks and troughs in suicide rates can help psychiatrists to be particularly alert to the warning signs at times of highest risk. One influence thought to have particular importance is that of season.

It is a commonly-held belief that, at times like Christmas, depressive symptoms such as stress and loneliness are likely to feel more pronounced3. Likewise, studies have observed that bipolar I sufferers experience a significant peak in severe depressive symptoms during the winter months, when days are shorter.4

Based on these pieces of accepted wisdom, one might expect the season with the highest rates of suicide, and therefore the need for greatest awareness, to be winter. However, the evidence overwhelmingly points to the opposite, a peak in suicides during spring and summer, especially pronounced in those suffering mood disorders such as bipolar I disorder.5-7

 

Light and darkness

 

The reasons for this peak are still unclear. Possible explanations range from the effects of temperature or atmospheric pressure to the Th2-mediated worsening of depressive symptoms triggered by aeroallergens such as pollen.7

One compelling suggestion has been advanced by Professor Zoltan Rihmer. Professor Rihmer emphasises the important influence of sunlight in seasonality, promoting a hyperthymic temperament usually protective against suicide.

The problem, he suggests, arises when both manic and depressive symptoms are present concurrently. Here, the sudden boost in energy levels brought by the increased sunlight takes effect before improvements in mood, leading to a period where patients are both depressed and impulsive - a dangerous combination. This theory accords with the increased likelihood of suicide attempts seen in bipolar I patients suffering confirmed mania with depressive symptoms, as opposed to those suffering borderline/pure mania8.

So how can we use this information to lower the incidence of suicide attempts? One approach could be to focus on increasing early identification of mania with depressive features. There are a number of ways to achieve this, from indicator symptoms - such as anxiety, agitation and irritability - to diagnostic tools, such as the MINI. By improving identification of patients with mania with depressive features we can increase HCP vigilance not only during the period of highest suicide risk but also amongst the group most likely to be vulnerable during this time.

 

Keeping a steady watch

 

Whatever the causes, the spring/summer peak in suicides requires careful observation, especially as research suggests that as a patient’s suicide risk increases at this time, the likelihood of them recognising their own mental health issues and seeking help appears to fall.9

However, with preparation and appropriate use of diagnostic tools, physicians can begin to detect at-risk patients earlier, helping reduce suicide rates in bipolar I disorder by ever-greater numbers.

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References
  1. Bertolote JM and Fleischmann A. World Psychiatry. 2002; 1: 181–5.
  2. Jamison KR. J Clin Psychiatry. 2000 61 Suppl 9: 47-51.
  3. Hairon, N. Nursing Times 2008; 104: 33-34.
  4. Sansone RA and Sansone LA. Innov Clin Neurosci. 2013; 10: 20–24.
  5. Tsai J and Cho W. Psychiatry Res. 2011; 186: 147-149.
  6. Shojaei A. et al. Iranian J Publ Health 2013; 42: 293-297.
  7. Woo J. Int. J. Environ. Res. Public Health. 2012; 9: 531-547.
  8. Young A and Eberhard J. Poster presented at the International Society of Affective Disorders (ISAD) Congress, 28th – 30th April 2014, Berlin, Germany.
  9. Ayers JW et al. Am J Prev Med. 2013; 44: 5205.

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country